Application no. and date | 16711533.6 (espacenet) (Federated) (European Patent Register), 20160210 | Patent/reg. no. and date | DK/EP 3256162, 20231206 | Publication date | 20171220 | Priority no. and date | EP 15154629, 20150211 | EP pub. no. and date |
EP 3256162 20171220 | Effective date | | Applicant/owner | Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280 69120 Heidelberg , DE, Ruprecht-Karls-Universität, Grabengasse 1
69117 Heidelberg, DE | Applicant ref. no. | PV1840DKEP | Inventor | ROMMELAERE, Jean, Schloss-Wolfsbrunnenweg 11
69118 Heidelberg, DE, GELETNEKY, Karsten, Beethoven-Str. 35
69121 Heidelberg, DE, WICK, Wolfgang, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE, WICK, Antje, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE, DAHM, Michael, Saalestr. 5
81677 München, DE | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 35/768 (2015.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/22 (2006.01) | Title | KRÆFTBEHANDLING MED EN PARVOVIRUS KOMBINERET MED BEVACIZUMAB | Int. application no. | EP2016025008 | Int. publication no. | WO2016128146 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|